BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19515443)

  • 1. Applicator reconstruction and applicator shifts in 3D MR-based PDR brachytherapy of cervical cancer.
    De Leeuw AA; Moerland MA; Nomden C; Tersteeg RH; Roesink JM; Jürgenliemk-Schulz IM
    Radiother Oncol; 2009 Nov; 93(2):341-6. PubMed ID: 19515443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer.
    Jürgenliemk-Schulz IM; Tersteeg RJ; Roesink JM; Bijmolt S; Nomden CN; Moerland MA; de Leeuw AA
    Radiother Oncol; 2009 Nov; 93(2):322-30. PubMed ID: 19748695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
    Lindegaard JC; Tanderup K; Nielsen SK; Haack S; Gelineck J
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):756-64. PubMed ID: 18191335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer.
    Tanderup K; Hellebust TP; Lang S; Granfeldt J; Pötter R; Lindegaard JC; Kirisits C
    Radiother Oncol; 2008 Nov; 89(2):156-63. PubMed ID: 18692265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
    Kirisits C; Pötter R; Lang S; Dimopoulos J; Wachter-Gerstner N; Georg D
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):901-11. PubMed ID: 15936576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer.
    Haack S; Nielsen SK; Lindegaard JC; Gelineck J; Tanderup K
    Radiother Oncol; 2009 May; 91(2):187-93. PubMed ID: 18977049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma.
    De Brabandere M; Mousa AG; Nulens A; Swinnen A; Van Limbergen E
    Radiother Oncol; 2008 Aug; 88(2):217-26. PubMed ID: 18037524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining DVH parameters for combined external beam and brachytherapy treatment: 3D biological dose adding for patients with cervical cancer.
    Van de Kamer JB; De Leeuw AA; Moerland MA; Jürgenliemk-Schulz IM
    Radiother Oncol; 2010 Feb; 94(2):248-53. PubMed ID: 20080309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct reconstruction of the Vienna applicator on MR images.
    Berger D; Dimopoulos J; Pötter R; Kirisits C
    Radiother Oncol; 2009 Nov; 93(2):347-51. PubMed ID: 19625096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
    Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter- and intraobserver variation in HR-CTV contouring: intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy.
    Petric P; Dimopoulos J; Kirisits C; Berger D; Hudej R; Pötter R
    Radiother Oncol; 2008 Nov; 89(2):164-71. PubMed ID: 18789829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.
    Chargari C; Magné N; Dumas I; Messai T; Vicenzi L; Gillion N; Morice P; Haie-Meder C
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):133-9. PubMed ID: 18774656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Petersen JB; Nielsen SK; Lindegaard JC; Tanderup K
    Acta Oncol; 2008; 47(7):1337-43. PubMed ID: 18663651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations.
    Lang S; Nulens A; Briot E; Kirisits C; De Brabandere M; Dumas I; Dimopoulos J; Petrow P; Georg D; Van Limbergen E; Haie-Meder C; Pötter R
    Radiother Oncol; 2006 Feb; 78(2):185-93. PubMed ID: 16466820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results.
    Kirisits C; Lang S; Dimopoulos J; Berger D; Georg D; Pötter R
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):624-30. PubMed ID: 16690444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncertainty analysis for 3D image-based cervix cancer brachytherapy by repetitive MR imaging: assessment of DVH-variations between two HDR fractions within one applicator insertion and their clinical relevance.
    Lang S; Nesvacil N; Kirisits C; Georg P; Dimopoulos JC; Federico M; Pötter R
    Radiother Oncol; 2013 Apr; 107(1):26-31. PubMed ID: 23541645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
    Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of applying a single treatment plan for both fractions in PDR image guided brachytherapy in cervix cancer.
    Mohamed S; Nielsen SK; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
    Radiother Oncol; 2013 Apr; 107(1):32-8. PubMed ID: 23333020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of alternative biological modelling parameters (α/β and half time of repair T ½ ) on reported EQD2 values in the treatment of advanced cervical cancer.
    De Leeuw AA; Van de Kamer JB; Moerland MA; Philippens ME; Jürgenliemk-Schulz IM
    Radiother Oncol; 2011 Nov; 101(2):337-42. PubMed ID: 21742393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse planning simulated annealing for magnetic resonance imaging-based intracavitary high-dose-rate brachytherapy for cervical cancer.
    Kubicky CD; Yeh BM; Lessard E; Joe BN; Speight JL; Pouliot J; Hsu IC
    Brachytherapy; 2008; 7(3):242-7. PubMed ID: 18468959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.